Orexo’s annual report for 2012 released
Orexo’s annual report for the 2012 fiscal year has been published and can be downloaded from the investor section of the company’s homepage www.orexo.com . For further information, please contact:Beata Augenblick, Investor RelationsTel: +46-18 780 88 50E-mail: beata.augenblick@orexo.com About OrexoOrexo AB is an emerging specialty pharma company developing improved treatments using proprietary drug delivery technology. Orexo’s expertise is within the area of reformulation technologies and especially sublingual